Two Sigma Securities’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Two Sigma Securities’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,457	Closed	-$217K	–	1080
2016 Q3	$217K	Buy	+5,457	New	+$60.9K	0.07%	411
2015 Q1	–	Sell	-1,169	Closed	-$10K	–	370
2014 Q4	$10K	Buy	+1,169	New	+$10.1K	0.01%	240

Two Sigma Securities's TBRA Position: Q4 2016 in Review

Two Sigma Securities sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 5,457 shares — an estimated $217K sold.

Two Sigma Securities first reported a position in TBRA in Q4 2014 and held it in 2 quarters. The position peaked at $217K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Two Sigma Securities reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Two Sigma Securities sold 5,457 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $217K.
Two Sigma Securities first reported a position in Tobira Therapeutics, Inc. Common Stock in Q4 2014 and held it in 2 quarters.
Two Sigma Securities's Tobira Therapeutics, Inc. Common Stock position peaked at $217K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Two Sigma Securities's 13F filing for Q4 2016, filed 14 Feb 2017.